|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ashtari S, Pourhoseingholi MA, Sharifian A
and Zali MR: Hepatocellular carcinoma in Asia: Prevention strategy
and planning. World J Hepatol. 7:1708–1717. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gong B, Kao Y, Zhang C, Sun F and Zhao H:
Systematic Investigation of scutellariae barbatae herba for
treating hepatocellular carcinoma based on network pharmacology.
Evid Based Complement Alternat Med. 2018:43657392018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Du L, Li Y, Kang M, Feng M, Ren Y, Dai H,
Wang Y, Wang Y and Tang B: USP48 is upregulated by Mettl14 to
attenuate hepatocellular carcinoma via regulating SIRT6
stabilization. SIRT6 stabilization. Cancer Res. 81:3822–3834. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cheng X, Li M, Rao X, Zhang W, Li X, Wang
L and Huang G: KIAA1429 regulates the migration and invasion of
hepatocellular carcinoma by altering m6A modification of ID2 mRNA.
Onco Targets Ther. 12:3421–3428. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pan T: N6-methyl-adenosine modification in
messenger and long non-coding RNA. Trends Biochem Sci. 38:204–209.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tu Z, Wu L, Wang P, Hu Q, Tao C, Li K,
Huang K and Zhu X: N6-methylandenosine-related lncRNAs are
potential biomarkers for predicting the overall survival of
lower-grade glioma patients. Front Cell Dev Biol. 8:6422020.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang B, Wu Q, Li B, Wang D, Wang L and
Zhou YL: m6A regulator-mediated methylation modification
patterns and tumor microenvironment infiltration characterization
in gastric cancer. Mol Cancer. 19:532020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang Z, Zhang C, Luo Y, Wu P, Zhang G,
Zeng Q, Wang L, Yang Z, Xue L, Zheng B, et al: m6A
regulator expression profile predicts the prognosis, benefit of
adjuvant chemotherapy, and response to anti-PD-1 immunotherapy in
patients with small-cell lung cancer. BMC Med. 19:2842021.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu X, Mao Y, Feng Z, Dai F, Gu T and Zheng
J: SENP1 inhibits ferroptosis and promotes head and neck squamous
cell carcinoma by regulating ACSL4 protein stability via SUMO1.
Oncol Rep. 51:342024. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Meyer KD, Saletore Y, Zumbo P, Elemento O,
Mason CE and Jaffrey SR: Comprehensive analysis of mRNA methylation
reveals enrichment in 3′ UTRs and near stop codons. Cell.
149:1635–1646. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dominissini D, Moshitch-Moshkovitz S,
Schwartz S, Salmon-Divon M, Ungar L, Osenberg S, Cesarkas K,
Jacob-Hirsch J, Amariglio N, Kupiec M, et al: Topology of the human
and mouse m6A RNA methylomes revealed by m6A-seq. Nature.
485:201–206. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jiang X, Liu B, Nie Z, Duan L, Xiong Q,
Jin Z, Yang C and Chen Y: The role of m6A modification in the
biological functions and diseases. Signal Transduct Target Ther.
6:742021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Niu Y, Zhao X, Wu YS, Li MM, Wang XJ and
Yang YG: N6-methyl-adenosine (m6A) in RNA: An old modification with
a novel epigenetic function. Genomics Proteomics Bioinformatics.
11:8–17. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Han J, Kong H, Wang X and Zhang XA: Novel
insights into the interaction between N6-methyladenosine
methylation and noncoding RNAs in musculoskeletal disorders. Cell
Prolif. 55:e132942022. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen M, Wei L, Law CT, Tsang FHC, Shen J,
Cheng CLH, Tsang LH, Ho DWH, Chiu DKC, Lee JMF, et al: RNA
N6-methyladenosine methyltransferase-like 3 promotes liver cancer
progression through YTHDF2-dependent posttranscriptional silencing
of SOCS2. Hepatology. 67:2254–2270. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dai YZ, Liu YD, Li J, Chen MT, Huang M,
Wang F, Yang QS, Yuan JH and Sun SH: METTL16 promotes
hepatocellular carcinoma progression through downregulating
RAB11B-AS1 in an m6A-dependent manner. Cell Mol Biol
Lett. 27:412022. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
You Y, Wen D, Zeng L, Lu J, Xiao X, Chen
Y, Song H and Liu Z: ALKBH5/MAP3K8 axis regulates PD-L1+ macrophage
infiltration and promotes hepatocellular carcinoma progression. Int
J Biol Sci. 18:5001–5018. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li Q, Ni Y, Zhang L, Jiang R, Xu J, Yang
H, Hu Y, Qiu J, Pu L, Tang J and Wang X: HIF-1α-induced expression
of m6A reader YTHDF1 drives hypoxia-induced autophagy and
malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14
translation. Signal Transduct Target Ther. 6:762021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang C, Huang S, Zhuang H, Ruan S, Zhou
Z, Huang K, Ji F, Ma Z, Hou B and He X: YTHDF2 promotes the liver
cancer stem cell phenotype and cancer metastasis by regulating OCT4
expression via m6A RNA methylation. Oncogene. 39:4507–4518. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhou R, Ni W, Qin C, Zhou Y, Li Y, Huo J,
Bian L, Zhou A and Li J: A functional loop between YTH domain
family protein YTHDF3 mediated m6A modification and
phosphofructokinase PFKL in glycolysis of hepatocellular carcinoma.
J Exp Clin Cancer Res. 41:3342022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Luo J, Zheng J, Hao W, Zeng H, Zhang Z and
Shao G: lncRNA PCAT6 facilitates cell proliferation and invasion
via regulating the miR-326/hnRNPA2B1 axis in liver cancer. Oncol
Lett. 21:4712021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang Y, Wu J, Liu F, He J, Wu F, Chen J
and Jiang Z: IGF2BP1 promotes the liver cancer stem cell phenotype
by regulating MGAT5 mRNA stability by m6A RNA methylation. Stem
Cells Dev. 30:1115–1125. 2021.PubMed/NCBI
|
|
25
|
Pu J, Wang J, Qin Z, Wang A, Zhang Y, Wu
X, Wu Y, Li W, Xu Z, Lu Y, et al: IGF2BP2 promotes liver cancer
growth through an m6A-FEN1-dependent mechanism. Front Oncol.
10:5788162020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yu H and Zhang Z: ALKBH5-mediated m6A
demethylation of lncRNA RMRP plays an oncogenic role in lung
adenocarcinoma. Mamm Genome. 32:195–203. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Guo T, Liu DF, Peng SH and Xu AM: ALKBH5
promotes colon cancer progression by decreasing methylation of the
lncRNA NEAT1. Am J Transl Res. 12:4542–4549. 2020.PubMed/NCBI
|
|
28
|
Qian X, Yang J, Qiu Q, Li X, Jiang C, Li
J, Dong L, Ying K, Lu B, Chen E, et al: LCAT3, a novel
m6A-regulated long non-coding RNA, plays an oncogenic role in lung
cancer via binding with FUBP1 to activate c-MYC. J Hematol Oncol.
14:1122021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen X, Zhang L, Geng J, Chen Z and Cui X:
MiR-205-5p functions as a tumor suppressor in gastric cancer cells
through downregulating FAM84B. J Oncol. 2022:82678912022.PubMed/NCBI
|
|
30
|
Gulei D, Magdo L, Jurj A, Raduly L,
Cojocneanu-Petric R, Moldovan A, Moldovan C, Florea A, Pasca S, Pop
LA, et al: The silent healer: miR-205-5p up-regulation inhibits
epithelial to mesenchymal transition in colon cancer cells by
indirectly up-regulating E-cadherin expression. Cell Death Dis.
9:662018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kan J, Fu B, Zhou R, Zhou D, Huang Y, Zhao
H, Zhang Y, Rong Y, Dong J, Xia L, et al: He-Chan Pian inhibits the
metastasis of non-small cell lung cancer via the
miR-205-5p-mediated regulation of the GREM1/Rap1 signaling pathway.
Phytomedicine. 94:1538212022. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Toro AU, Shukla SK and Bansal P: Micronome
revealed miR-205-5p as key regulator of VEGFA during cancer related
angiogenesis in hepatocellular carcinoma. Mol Biotechnol.
65:1178–1186. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu X, Chen D, Chen H, Wang W, Liu Y, Wang
Y, Duan C, Ning Z, Guo X, Otkur W, et al: YB1 regulates
miR-205/200b-ZEB1 axis by inhibiting microRNA maturation in
hepatocellular carcinoma. Cancer Commun (Lond). 41:576–595. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yi L, He S, Cheng Z, Chen X, Ren X and Bai
Y: DNAJA1 stabilizes EF1A1 to promote cell proliferation and
metastasis of liver cancer mediated by miR-205-5p. J Oncol.
2022:22924812022. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shao P, Qu WK, Wang CY, Tian Y, Ye ML, Sun
DG, Sui JD, Wang LM, Fan R and Gao ZM: MicroRNA-205-5p regulates
the chemotherapeutic resistance of hepatocellular carcinoma cells
by targeting PTEN/JNK/ANXA3 pathway. Am J Transl Res. 9:4300–4307.
2017.PubMed/NCBI
|
|
36
|
Denisenko ON, O'Neill B, Ostrowski J, Van
Seuningen I and Bomsztyk K: Zik1, a transcriptional repressor that
interacts with the heterogeneous nuclear ribonucleoprotein particle
K protein. J Biol Chem. 271:27701–27706. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ota T, Suzuki Y, Nishikawa T, Otsuki T,
Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, et al:
Complete sequencing and characterization of 21,243 full-length
human cDNAs. Nat Genet. 36:40–45. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu Y, Yang Z, Du F, Yang Q, Hou J, Yan X,
Geng Y, Zhao Y and Wang H: Molecular mechanisms of pathogenesis in
hepatocellular carcinoma revealed by RNA-sequencing. Mol Med Rep.
16:6674–6682. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu P, Jiang W, Zhao J and Zhang H:
Integrated analysis of genome-wide gene expression and DNA
methylation microarray of diffuse large B-cell lymphoma with TET
mutations. Mol Med Rep. 16:3777–3782. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Oka D, Yamashita S, Tomioka T, Nakanishi
Y, Kato H, Kaminishi M and Ushijima T: The presence of aberrant DNA
methylation in noncancerous esophageal mucosae in association with
smoking history: A target for risk diagnosis and prevention of
esophageal cancers. Cancer. 115:3412–3426. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mihara M, Yoshida Y, Tsukamoto T, Inada
KI, Nakanishi Y, Yagi Y, Imai K, Sugimura T, Tatematsu M and
Ushijima T: Methylation of multiple genes in gastric glands with
intestinal metaplasia: A disorder with polyclonal origins. Am J
Pathol. 169:1643–1651. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ni JS, Zheng H, Huang ZP, Hong YG, Ou YL,
Tao YP, Wang MC, Wang ZG, Yang Y and Zhou WP: MicroRNA-197-3p acts
as a prognostic marker and inhibits cell invasion in hepatocellular
carcinoma. Oncol Lett. 17:2317–2327. 2019.PubMed/NCBI
|
|
43
|
Deng X, Su R, Weng H, Huang H, Li Z and
Chen J: RNA N(6)-methyladenosine modification in cancers: Current
status and perspectives. Cell Res. 28:507–517. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ma JZ, Yang F, Zhou CC, Liu F, Yuan JH,
Wang F, Wang TT, Xu QG, Zhou WP and Sun SH: METTL14 suppresses the
metastatic potential of hepatocellular carcinoma by modulating
N6-methyladenosine-dependent primary MicroRNA processing.
Hepatology. 65:529–543. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lin S, Choe J, Du P, Triboulet R and
Gregory RI: The m(6)A methyltransferase METTL3 promotes translation
in human cancer cells. Mol Cell. 62:335–345. 2016. View Article : Google Scholar : PubMed/NCBI
|
